Cambridge Cognition strong growth in revenue of 31% to £5.9 million

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced strong growth for the six months ended 30 June 2022.

The unaudited financial highlights for the six months ended 30 June 2022 are:

·          Increase in like-for-like sales orders of 44% to £7.2 million (H1 2021: £8.6 million including £3.6 million of one-off orders)

·          Growth in revenue of 31% to £5.9 million (H1 2021: £4.5 million)

·          Increase in contracted order book of £1.5m million since the last year end to £18.6 million (31 December 2021: £17.1 million)

·          Profit after tax in line with expectations at £0.02 million (H1 2021: £0.1 million)

·          Continued growth in cash balances at 30 June 2022 to £8.6 million (31 December 2021: £6.8 million)

The Company followed up its strong performance in 2021 with a considerable growth in revenues to £5.9 million in the first half of 2022, which is up 31% on H1 2021 (H1 2021: £4.5 million).  Order intake was in line with the Board’s expectations at £7.2 million, up 44% on a like-for-like basis on H1 2021 (H1 2021: £8.6 million including £3.6 million of one-off orders) and the Company has a healthy and growing qualified pipeline of opportunities for the second half of 2022. 

The contracted order book was £18.6 million at 30 June 2022, an increase of £1.5 million since the start of the year.  The order book provides the Company with visibility over future revenues and provides a solid foundation from which the Company can continue with its plans to invest in product and commercial development to further expand the business.

Trading conditions continue to be positive and the Company has high levels of engagement with existing and potential new clients.  With continued investment in commercial activities and product development, the Company expects to achieve further year-on-year revenue growth.  The cash position continues to grow to £8.6 million at 30 June 2022 and provides the business with the platform to make considered investments as opportunities arise.

Notice of Results

The interim results for the six months ended 30 June 2022 will be announced on 20 September 2022.

The Company will conduct a live presentation and Q&A session for investors on the same day at 5:30 pm BST. The presentation is open to all existing and potential shareholders.  Those wishing to attend should email cog@investor-focus.co.uk and they will be provided with log in details.  There will be the opportunity for participants to ask questions at the end of the presentation.  Questions can also be emailed to the above address ahead of the presentation.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition 25% growth in revenues to £12.6 million

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a trading update for the year ended 31 December 2022. Unaudited highlights for the year ended 31 December 2022 ·         Revenue ahead of

Cambridge Cognition Holdings

Cambridge Cognition acquires Winterlight Labs Inc

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced the acquisition of Winterlight Labs Inc, a leader in monitoring cognitive impairment through free-speech analysis.  The total consideration for the Acquisition is

Cambridge Cognition Holdings

Cambridge Cognition plc investor live webinar today

The interim results for the six months ended 30 June 2022 were released earlier today on 20 September 2022. The Company will conduct a live presentation and Q&A session for investors later today at 5:30 pm BST. The presentation

Cambridge Cognition Holdings

Cambridge Cognition growth in revenue of 31%

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2022. The Company followed its strong performance in 2021 with a 31%

Cambridge Cognition Holdings

Cambridge Cognition partnering with the University of Oxford

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it will be collaborating with the University of Oxford by providing cognitive assessments for the Impact of Semaglutide in Amyloid

Cambridge Cognition Holdings

Cambridge Cognition signs two PTSD trial agreements

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced two agreements in a new therapeutic area for the Company, post-traumatic stress disorder.  Most recently, a research agreement was entered into

Cambridge Cognition Holdings

Cambridge Cognition directors buy shares in company

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, announced today that it was informed on the 21st July 2022 of the following purchases of the Company’s ordinary shares by Directors and PDMRs of the

Cambridge Cognition Holdings

Cambridge Cognition to announce preliminary results on 12 April 2022

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, will announce its preliminary results for the year ended 31 December 2021 on 12 April 2022. Cambridge Cognition is a technology company developing digital

No more posts to show